In vitro–in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin

References

• Konturek SJ, Konturek PC, Pawlik T, Sliwowski Z, Ochmański W, Hahn EG. Duodenal mucosal protection by bicarbonate secretion and its mechanisms. J Physiol Pharmacol. 2004;55(2):5–17.15608357
   PubMedGoogle Scholar
• Bruntan LL, Lazo JS, Parker KL. Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill Companies; 2006.
   Google Scholar
• Ai F, Ma Y, Wang J, Li Y. Preparation, physicochemical characterization and in-vitro dissolution studies of diosmin-cyclodextrin inclusion complexes. Iran J Pharm Res. 2014;13(4):1115–1123.25587299
   PubMed Web of Science ®Google Scholar
• Tong N, Zhang Z, Zhang W, et al. Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury. PLoS One. 2013;8(4):e61794. doi:10.1371/journal.pone.006179423637907
   PubMedGoogle Scholar
• Vrbata P, Berka P, Stránská D, Doležal P, Lázníček M. Electrospinning of diosmin from aqueous solutions for improved dissolution and oral absorption. Int J Pharm. 2014;473(1–2):407–413. doi:10.1016/j.ijpharm.2014.07.01725066074
   PubMed Web of Science ®Google Scholar
• Anwer MK, Jamil S, Ansari MJ, et al. Water soluble binary and ternary complexes of diosmin with β-cyclodextrin: spectroscopic characterization, release studies and anti-oxidant activity. J Mol Liq. 2014;199:35–41. doi:10.1016/j.molliq.2014.08.012
   Web of Science ®Google Scholar
• Arab HH, Salama SA, Omar HA, Arafa E-SA, Maghrabi IA. Diosmin protects against ethanol-induced gastric injury in rats: novel anti-ulcer actions. PLoS One. 2015;10(3):e0122417. doi:10.1371/journal.pone.012241725821971
   PubMed Web of Science ®Google Scholar
• Russo R, Chandradhra D, De Tommasi N. Comparative bioavailability of two diosmin formulations after oral administration to healthy volunteers. Molecules. 2018;23(9):pii:E2174. doi:10.3390/molecules23092174
   Web of Science ®Google Scholar
• Freag MS, Elnaggar YS, Abdallah OY. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Int J Pharm. 2013;454(1):462–471. doi:10.1016/j.ijpharm.2013.06.03923830765
   PubMedGoogle Scholar
• Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. Mucoadhesive DL- lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol. 2000;5(1):77–85. doi:10.1081/PDT-10010052210669921
   PubMed Web of Science ®Google Scholar
• Garner RC, Garner JV, Gregory S, Whattam M, Calam A, Leong D. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J Pharm Sci. 2002;91(1):32–40. doi:10.1002/jps.1005211782895
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3):1377–1397. doi:10.3390/polym303137722577513
   PubMed Web of Science ®Google Scholar
• Derman S. Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency and particle size. J Nanomater. 2015;16:1–12. doi:10.1155/2015/341848
   Google Scholar
• Sanna V, Roggio AM, Siliani S, et al. Development of novel cationic chitosan- and anionic alginate–coated poly(d,l-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int J Nanomedicine. 2012;7:5501–5516. doi:10.2147/IJN.S3668423093904
   PubMed Web of Science ®Google Scholar
• Kim BS, Kim CS, Lee KM. The intracellular uptake ability of chitosan-coated poly (d,l-lactideco-glycolide) nanoparticles. Arch Pharm Res. 2008;31(8):1050–1054. doi:10.1007/s12272-001-1267-518787796
   PubMed Web of Science ®Google Scholar
• Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine. 2007;3(3):173–183. doi:10.1016/j.nano.2007.03.00617692575
   PubMed Web of Science ®Google Scholar
• Slütter B, Bal S, Keijzer C, et al. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen. Vaccine. 2010;28(38):6282–6291. doi:10.1016/j.vaccine.2010.06.12120638455
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Preparation and characterization of insulin loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Sci. 2012;45(5):632–638. doi:10.1016/j.ejps.2012.01.00222248882
   PubMed Web of Science ®Google Scholar
• Wang Y, Li P, Kong L. Chitosan modified PLGA nanoparticles with versatile surface for improved drug delivery. AAPS PharmSciTech. 2013;14(2):585–592. doi:10.1208/s12249-013-9943-323463262
   PubMed Web of Science ®Google Scholar
• Alqahtani S, Simon L, Astete CE, et al. Cellular uptake, antioxidant and antiproliferative activity of entrapped α-tocopherol and γ-tocotrienol in poly(lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles(PLGA-Chi). J Colloid Interface Sci. 2015;445:243–251. doi:10.1016/j.jcis.2014.12.08325622049
   PubMed Web of Science ®Google Scholar
• Chronopoulou L, Massimi M, Giardi MF, et al. Chitosan coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Colloids Surf B Biointerfaces. 2013;103:310–317. doi:10.1016/j.colsurfb.2012.10.06323261553
   PubMed Web of Science ®Google Scholar
• Chuah LH, Billa N, Roberts CJ, Burley JC, Manickam S. Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon. Pharm Dev Technol. 2013;18(3):591–599. doi:10.3109/10837450.2011.64068822149945
   PubMed Web of Science ®Google Scholar
• Bigucci F, Luppi B, Cerchiara T, et al. Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur J Pharm Sci. 2008;35(5):435–441. doi:10.1016/j.ejps.2008.09.00418951977
   PubMed Web of Science ®Google Scholar
• Kumar R, Philip A. Gastroretentive dosage forms for prolonging gastric residence time. Int J Pharm Med. 2007;21(2):157–171. doi:10.2165/00124363-200721020-00005
   Google Scholar
• Mohammadi-Samani S, Taghipour B. PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches. Pharm Dev Technol. 2015;20(4):385–393. doi:10.3109/10837450.2014.88294024483777
   PubMed Web of Science ®Google Scholar
• Lassalle V, Ferreira ML. PLA nano- and microparticles for drug delivery: an overview of the methods of preparation. Macromol Biosci. 2007;7:767–783. doi:10.1002/(ISSN)1616-519517541922
   PubMed Web of Science ®Google Scholar
• Lai P, Daear W, Löbenberg R, Prenner EJ. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate. Colloids Surf B Biointerfaces. 2014;118:154–163. doi:10.1016/j.colsurfb.2014.03.01724769392
   PubMed Web of Science ®Google Scholar
• Mahmoodi M, Khosroshahi ME, Atyabi F. Laser thrombolysis and in vitro study of tPA release encapsulated by chitosan coated PLGA nanoparticles for AMI. Int J Biol Biomed Eng. 2010;4(2):35–42.
   Google Scholar
• Mohamed EA, Abu Hashim II, Yusif RM, et al. Polymeric micelles for potentiated antiulcer and anticancer activities of naringin. Int J Nanomedicine. 2018;13:1009–1027. doi:10.2147/IJN.S15432529497294
   PubMed Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 2007;119(1):77–85. doi:10.1016/j.jconrel.2007.02.00517349712
   PubMed Web of Science ®Google Scholar
• Martin AN, Swarbrick J, Cammarata A. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. 4th ed. Lea & Febiger, editors Philadelphia; 1993.
   Google Scholar
• Higuchi T. Mechanism of sustained action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145–1149. doi:10.1002/jps.260052121014088963
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5(1):23–36. doi:10.1016/0168-3659(87)90034-4
   Google Scholar
• Suwannateep N, Banlunara W, Wanichwecharungruang SP, Chiablaem K, Lirdprapamongkol K, Svasti J. Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J Control Release. 2011;151(2):176–182. doi:10.1016/j.jconrel.2011.01.01121241751
   PubMed Web of Science ®Google Scholar
• El-Maraghy SA, Rizk SM, Shahin NN. Gastroprotective effect of crocin in ethanol-induced gastric injury in rats. Chem Biol Interact. 2015;229:26–35. doi:10.1016/j.cbi.2015.01.01525637687
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Stevens A, Turner DR. Theory and Practice of Histological Techniques. 4th ed. New York: Churchill Livingstone; 1996.
   Google Scholar
• Laine L, Weinstein WM. Histology of alcoholic hemorrhagic “gastritis”: a prospective evaluation. Gastroenterology. 1988;94(6):1254–1262. doi:10.1016/0016-5085(88)90661-03258836
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm. 2007;336(2):367–375. doi:10.1016/j.ijpharm.2006.11.06117207944
   PubMed Web of Science ®Google Scholar
• Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci. 2004;93(7):1804–1814. doi:10.1002/jps.2009415176068
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. Praziquantel-loaded PLGA nanoparticles: preparation and characterization. J Microencapsul. 2005b;22(1):13–24. doi:10.1080/0265204040002628516019887
   PubMed Web of Science ®Google Scholar
• Hussein AS, Abdullah N, Fakru’l-Razi A. Optimizing the process parameters for encapsulation of linamarin into PLGAnanoparticles using doublee mulsion solvent evaporation technique. Adv Polym Tech. 2013;32(1):E486–E504. doi:10.1002/adv.21295
   Google Scholar
• Beck-Broichsitter M, Rytting E, Lebhardt T, Wang X, Kissel T. Preparation of nanoparticles by solvent displacement for drug delivery: a shift in the “ouzo region” upon drug loading. Eur J Pharm Sci. 2010;41(2):244–253. doi:10.1016/j.ejps.2010.06.00720600881
   PubMed Web of Science ®Google Scholar
• Song KC, Lee HS, Choung IY, Cho KI, Ahn Y, Choi EJ. The effect of type of organic phase solvents on the particle size of poly(d,l-lactide-co-glycolide) nanoparticles. Colloids Surf A Physicochem Eng Asp. 2006;276(1–3):162–167. doi:10.1016/j.colsurfa.2005.10.064
   Web of Science ®Google Scholar
• Semete B, Booysen LI, Kalombo L, et al. In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol Appl Pharmacol. 2010;249(2):158–165. doi:10.1016/j.taap.2010.09.00220851137
   PubMed Web of Science ®Google Scholar
• Sahoo KS, Panyama J, Prabhaa S, Labhasetwara V. Residual polyvinyl alcohol associated with poly (D,L-lactide-coglycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105–114. doi:10.1016/S0168-3659(02)00127-X12106981
   PubMed Web of Science ®Google Scholar
• Müller RH, Jacobs C. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int J Pharm. 2002;237(1–2):151–161. doi:10.1016/S0378-5173(02)00040-611955813
   PubMed Web of Science ®Google Scholar
• Yang J, Lee CH, Park J, et al. Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer. J Mater Chem. 2007;17:2695–2699. doi:10.1039/b702538f
   Web of Science ®Google Scholar
• Singh G, Kaur T, Kaur R, Kaur A. Recent biomedical applications and patents on biodegradable polymer-PLGA. Int J Pharmacol Pharm Sci. 2014;1(2):30–42.
   Google Scholar
• Roy P, Das S, Bera T, Mondol S, Mukherjee A. Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations. Int J Nanomedicine. 2010;5:1113–1121. doi:10.2147/IJN.S1478721270962
   PubMed Web of Science ®Google Scholar
• Hanafy AS, Farid RM, ElGamal SS. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer’s disease management: preparation and detection in rat brain. Drug Dev Ind Pharm. 2015;41(12):2055–2068. doi:10.3109/03639045.2015.106289726133084
   PubMed Web of Science ®Google Scholar
• Salem AE, Mohamed EA, Elghadban HM, Abdelghani GM. Potential combination topical therapy of anal fissure: development, evaluation, and clinical study. Drug Deliv. 2018;25(1):1672–1682. doi:10.1080/10717544.2018.150705930430875
   PubMed Web of Science ®Google Scholar
• Anwer MK, Al-Mansoor MA, Jamil S, Al-Shdefat R, Ansari MN, Shakeel F. Development and evaluation of PLGA polymer based nanoparticles of quercetin. Int J Biol Macromol. 2016;92:213–219. doi:10.1016/j.ijbiomac.2016.07.00227381585
   PubMed Web of Science ®Google Scholar
• Anwer MK, Mohammad M, Ezzeldin E, Fatima F, Alalaiwe A, Iqbal M. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomedicine. 2019;14:1587–1595. doi:10.2147/IJN.S19504830880967
   PubMed Web of Science ®Google Scholar
• Barbi Mda S, Carvalho FC, Kiill CP, et al. Preparation and characterization of chitosan nanoparticles for zidovudine nasal delivery. J Nanosci Nanotechnol. 2015;15(1):865–874. doi:10.1166/jnn.2015.918026328451
   PubMedGoogle Scholar
• Cortivo R, Vindigni V, Iacobellis L, Abatangelo G, Pinton P, Zavan B. Nanoscale particle therapies for wounds and ulcers. Nanomedicine. 2010;5(4):641–656. doi:10.2217/nnm.10.220528458
   PubMed Web of Science ®Google Scholar
• Prabha S, Zhou W-Z, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm. 2002;244(1–2):105–115.12204570
   PubMed Web of Science ®Google Scholar
• Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 2005;44(2–3):65–73. doi:10.1016/j.colsurfb.2005.06.00116024239
   PubMed Web of Science ®Google Scholar
• Wang J, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed. 2011;6:765–774.
   PubMed Web of Science ®Google Scholar
• Rodrigues S, Dionísio M, López CR, Grenha A. Biocompatibility of chitosan carriers with application in drug delivery. J Funct Biomater. 2012;3(3):615–641. doi:10.3390/jfb303061524955636
   PubMedGoogle Scholar
• Pandey R, Khuller GK. Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers. J Antimicrob Chemother. 2004;53:635–640. doi:10.1093/jac/dkh13914998985
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials. 2009;30:2329–2339. doi:10.1016/j.biomaterials.2008.12.06619176244
   PubMed Web of Science ®Google Scholar